Analysts expect Innoviva, Inc. (NASDAQ:INVA) to report $0.54 EPS on April, 26.They anticipate $0.39 EPS change or 260.00% from last quarter’s $0.15 EPS. INVA’s profit would be $54.61 million giving it 7.43 P/E if the $0.54 EPS is correct. After having $0.50 EPS previously, Innoviva, Inc.’s analysts see 8.00% EPS growth. The stock decreased 0.56% or $0.09 during the last trading session, reaching $16.05. About 945,055 shares traded. Innoviva, Inc. (NASDAQ:INVA) has risen 27.80% since April 17, 2017 and is uptrending. It has outperformed by 16.25% the S&P500.
Among 5 analysts covering Sienna Senior Living Inc. (TSE:SIA), 0 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. Sienna Senior Living Inc. had 25 analyst reports since August 12, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Thursday, November 10 by RBC Capital Markets. The stock of Sienna Senior Living Inc. (TSE:SIA) has “Market Perform” rating given on Wednesday, April 19 by Raymond James. The stock of Sienna Senior Living Inc. (TSE:SIA) has “Sector Perform” rating given on Friday, February 17 by Scotia Capital. Scotia Capital maintained the shares of SIA in report on Wednesday, August 12 with “Sector Perform” rating. Scotia Capital maintained it with “Sector Perform” rating and $18.25 target in Friday, August 12 report. The rating was maintained by BMO Capital Markets on Tuesday, May 30 with “Market Perform”. See Sienna Senior Living Inc. (TSE:SIA) latest ratings:
23/11/2017 Broker: BMO Capital Markets Rating: Old Target: $19.50 New Target: $20.00 Target Up
Sienna Senior Living Inc., through its subsidiaries, provides senior housing and long-term care services in Canada. The company has market cap of $1.15 billion. It operates through LTC business, Retirement, and Baltic divisions. It has a 40.07 P/E ratio. The firm owns and operates 35 LTC homes across Ontario with 5,733 beds; and 13 retirement residences representing 1,429 suites in the provinces of Ontario and British Columbia.
The stock increased 0.67% or $0.12 during the last trading session, reaching $18.03. About 169,932 shares traded. Sienna Senior Living Inc. (TSE:SIA) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.
Innoviva, Inc. engages in the development and commercialization of bio-pharmaceuticals. The company has market cap of $1.62 billion. The Company’s portfolio of respiratory products include RELVAR/BREO ELLIPTA, and ANORO ELLIPTA (umeclidinium bromide/ vilanterol, UMEC/VI). It has a 13.77 P/E ratio. The company, under its the Long-Acting Beta2 Agonist (LABA) collaboration agreement and the strategic alliance agreement with Glaxo Group Limited (GSK), is entitled to receive royalties on the sales of RELVAR/BREO ELLIPTA; and a 15% of any future payments made by GSK under its agreements relating to the combination FF/UMEC/VI and the Bifunctional Muscarinic Antagonist-Beta2 Agonist program, as monotherapy and in combination with other therapeutically active components.